In Vivo Positronium Lifetime Measurements with a Long Axial Field-of-View PET/CT
Lorenzo Mercolli,William M. Steinberger,Hasan Sari,Ali Afshar-Oromieh,Federico Caobelli,Maurizio Conti,Angelo R. Felgosa Cardoso,Clemens Mingels,Pawel Moskal,Thomas Pyka,Narendra Rathod,Robin Schepers,Robert Seifert,Kuangyu Shi,Ewa L. Stepien,Marco Viscione,Axel O. Rominger
DOI: https://doi.org/10.1101/2024.10.19.24315509
2024-10-22
Abstract:Purpose: The lifetime of orthopositronium (oPs), a spin triplet of an electron
and positron, depends on the molecular structure of the surrounding tissue.
Therefore, measuring oPs lifetime could in principle provide diagnostic information about the tissue microenvironment that goes beyond standard positron
emission tomography (PET) imaging. This study demonstrates that in vivo
oPs lifetime measurement is feasible with a commercial long axial field-of-view
(LAFOV) PET/CT scanner.
Methods: Three subjects received a dose of 148.8 MBq [68Ga]-Ga-DOTA-TOC,
159.7 MBq [68Ga]Ga-PSMA-617 and 420.7 MBq [82Rb]Cl. In addition to the
standard protocol, the three subjects were scanned for 20, 40 and 10 minutes
with a single-crystal interaction acquisition mode on a Biograph Vision Quadra
(Siemens Healthineers) PET/CT. Three-photon events, that include two anni-
hilation photons and a prompt photon from the decay of the radionuclide, are
then selected from the list mode data based on energy, time and spatial selection criteria using a prototype software. The spatial location of the annihilation
events is reconstructed using the annihilation photons' time-of-flight. Through a
Bayesian fit to the measured time difference between the annihilation and the
prompt photons, we are able to determine the oPs lifetime for selected organs.
The Bayesian fitting methodology is extended to a hierarchical model in order
to investigate possible common oPs lifetime distributions of the heart chambers
in the [82Rb]Cl scan.
Results: From the segmentation of the subjects' histoimages of three-photon
events, we present the highest density intervals (HDI) of the oPs lifetime's
marginalized posterior distribution for selected organs. Interestingly, the mean
values of the right heart chambers were higher than in the left heart chambers
of the subject that received [82Rb]Cl: the 68% HDI of the atria are [1.15 ns,
1.72 ns] (left) and [1.46 ns, 1.99 ns] (right) with mean values 1.50 ns and 1.76
ns, respectively. For the ventricles we obtained [1.22 ns, 1.60 ns] (left) and [1.69
ns, 2.18 ns] (right) with mean values 1.44 ns and 1.96 ns. This might signal the
different oxygenation levels of venous and arterial blood. Fitting a hierarchical
model, we found that the oPs lifetime for volumes-of-interest with arterial blood
can be sampled form a posterior distribution with a 68% HDI of [1.4 ns, 1.84
ns] (mean 1.62 ns) and while those containing venous blood have a HDI of [1.78
ns, 2.21 ns] (mean 2.0 ns). Through arterial and venous blood sampling, we were
unable to confirm such a difference in the oPs lifetime.
Conclusion: In vivo oPs lifetime measurements on a commercial LAFOV
PET/CT system are feasible at the organ level with an unprecedented level of
statistical power. Nevertheless, count statistics of three-photon events (especially
for 68Ga-based measurements) and the interpretation of oPs lifetimes in human
tissue remain major challenges that need to be addressed in future studies.
Keywords: Positronium, Long axial field-of-view PET/CT, [82Rb]Cl,
[68Ga]-PSMA-617, [68Ga]-DOTA-TOC